Chronic neuropathic pain (NP) is a debilitating condition that affects millions of people. One in five people live with chronic pain, and 30-40% of these individuals live with neuropathic pain. There are few treatment options for those with this condition, and many of the options come with multiple side effects which are hard to tolerate. Now, Sana Health, Inc , in partnership with Mt. Sinai Icahn School of Medicine Abilities Research Center, hopes to offer relief to those living with chronic neuropathic pain using their audiovisual Sana Device. The company has launched a study with 100 participants to assess the effectiveness of their device in treating chronic neuropathic pain. The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to use at home for 8-14 weeks. Sana health is currently completing several clinical trials . See if you qualify Chronic neuropathic pain has multiple and often severe consequences for people who live with the condition, their family members, and even society as a whole. Living with chronic pain, and especially neuropathic pain, negatively impacts people’s lives and impairs their ability to participate in day-to-day activities and to function at work or hold a job at all. In addition to the far-reaching effects on quality of life for pain patients, the cost to society is significant and lies in the range of billions of dollars . There are many causes of chronic neuropathic pain, and it is often related to underlying diseases or injuries. It can be caused by things like trauma, strokes, multiple sclerosis, shingles, diabetes, cancer, or hereditary conditions that affect the nervous system. Symptoms of neuropathic pain can occur in one part of the body or be more widespread. Patients often describe the pain they experience as burning, shooting, or electrical, and it is often accompanied by tingling or numbness. On top of physical symptoms of pain, most neuropathic pain patients experience other symptoms such as changes in mood (which can sometimes lead to depression), anxiety, sleep disorders, memory-related issues, fatigue, and generally feelings of unwellness that can be hard to define. In an interview with Liza, a Mighty Community Leader, she shared this about her experience living with chronic neuropathic pain: “I’ve lived with neuropathic pain for over a decade. It feels like forever, and I can’t remember life without pain. I am always in pain to some degree. It never goes away. It has impacted almost every part of my life, and some days I can barely get out of bed. It’s been very hard for me to find treatment that I can stay on. I always have to stop because the side effects are too much.” The Mighty is assisting Sana Health in recruitment for their user study for individuals in the U.S. diagnosed with chronic neuropathic pain who are seeking new options for symptom management. See if you’re eligible to try their device here. Learn More The device is a comfortable eye mask and earbud combination which gently uses audiovisual stimulation (AVS) to guide the wearer into a state of relaxation. Clinical data from Sana device treatments show that targeted AVS impact the central nervous system. In a 16-minute session, the Sana device provides a patented series of light and sound pulses, alternating eye-to-eye and ear-to-ear. These sessions can be done at home through an app paired to the device. As the algorithm moves through three phases the user relaxes into a deeper meditative state. At the conclusion of the treatment session with the device, individuals feel very relaxed and some fall asleep. Richard Hanbury, founder and CEO of Sana developed the Sana device after a Jeep accident in 1992 in Yemen left him with a spinal cord injury and chronic pain. After 14 months in the hospital, he was given a life expectancy of just five years. To address his own pain, he began to experiment with biometric sensors and neuromodulation patterns, hoping to recalibrate how his brain processed pain signals. The earliest prototype of the Sana device helped relieve his symptoms, and he went on to test it with the British and U.S. military services, Richard Branson’s Virgin Challenger flights, and the first Solar Impulse Flights. In 2016 he founded Sana Health to bring the technology to others who need it. “The therapeutic program provided in the 16-minute Sana session was refined over more than 25 years of trial and error by founder and inventor Richard Hanbury, in collaboration with neuroscientist Jeffrey Bower, PhD, who used EEG readings to validate the findings,” Sana Health told The Mighty. Users of the Sana device are finding relief for a range of symptoms, including pain, mood, and sleep disturbances. The device is breakthrough technology for anyone seeking non-drug treatment for symptoms related to chronic neuropathic pain. In fact, Sana has been awarded the status of Breakthrough Device Designation for the Sana device, for use in Fibromyalgia, from the Food and Drug Administration (FDA). This indicates that early testing shows that the device provides clinically meaningful improvement in symptom management for Fibromyalgia. With this status, Sana will receive priority when they submit Fibromyalgia studies for FDA approval. Users of the device speak well of its results. Jessica is a 44-year-old mother with Fibromyalgia, ankylosing spondylitis, and cancer. Her conditions left her fatigued and stressed, sleeping up to 16 hours a day at times. Regular use of the Sana device has helped her get better rest and left her with more energy. “With Sana, I am able to participate in life,” she said. “Something is centering me and something is grounding me. I can be in the moment.” The Mighty is excited about helping Sana Health recruit patients into this landmark clinical trial and about the promise of this technology to help those managing chronic neuropathic pain. If you’ve been diagnosed with chronic neuropathic pain and would like to learn more about how to participate in the study with Sana, see if you qualify here .